Cytek Biosciences (CTKB) EBIT Growth (3y) (2023 - 2026)
Cytek Biosciences (CTKB) EBIT Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 13.06% |
| 10 | Cytek Biosciences | 610.41 Mn | 536.56 Mn | 28.34 Mn | -7.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.69% |
| Mar 31, 2026 | -14.93% |
| Dec 31, 2025 | -309.35% |
| Sep 30, 2025 | -106.13% |
| Jun 30, 2025 | -128.46% |
| Mar 31, 2025 | -85.21% |
| Dec 31, 2024 | 31.37% |
| Sep 30, 2024 | -51.34% |
| Jun 30, 2024 | -61.82% |
| Mar 31, 2024 | -125.60% |
| Dec 31, 2023 | -26.36% |
| Sep 30, 2023 | -43.53% |
| Jun 30, 2023 | -247.24% |